Literature DB >> 6510502

Experimental alveolar echinococcosis. Suitability of a murine model of intrahepatic infection by Echinococcus multilocularis for immunological studies.

M Liance, D A Vuitton, S Guerret-Stocker, J P Carbillet, J A Grimaud, R Houin.   

Abstract

An experimental model of human alveolar echinococcosis was developed, using intrahepatic injection of E. multilocularis larvae in mice differing by their sensitivity to this parasite; it seems to be suitable for studying the relationship between cell-mediated immunity and a) growth of the parasite, b) development of fibrosis.

Entities:  

Mesh:

Year:  1984        PMID: 6510502     DOI: 10.1007/bf01951932

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  19 in total

1.  Decreased graft versus host reaction after intrahepatic lymphoid tissue implantation.

Authors:  R Eloy; D Vuitton; J P Vaultier; A Pousse; J F Grenier
Journal:  Cell Immunol       Date:  1976-02       Impact factor: 4.868

2.  Effect of partial hepatectomy on the graft versus host reaction after intrahepatic lymphoid tissue implantation.

Authors:  D Vuitton; R Eloy; G Coumaros; J F Grenier
Journal:  Cell Immunol       Date:  1977-01       Impact factor: 4.868

3.  Echinococcus multilocularis in the cotton rat. The effect of preexisting subcutaneous cysts on the development of a subsequent intraperitoneal inoculum of protoscolices.

Authors:  M E Rau; C E Tanner
Journal:  Can J Zool       Date:  1973-01       Impact factor: 1.597

4.  [Arvicola terrestris (L.), the first rodent found naturally infested with Echinosoccus multilocularis, Leuckart, 1863, in France].

Authors:  R Houin; M Deniau; M Liance
Journal:  C R Seances Acad Sci D       Date:  1980-05-19

5.  Echinococcus multilocularis: immunoglobulin and antibody response in C57BL/6J mice.

Authors:  Z Ali-Khan; R Siboo
Journal:  Exp Parasitol       Date:  1982-02       Impact factor: 2.011

6.  Immunoprophylaxis with BCG of experimental Echinococcus multilocularis infections.

Authors:  J M Reuben; C E Tanner; M E Rau
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441

7.  Host-parasite relationship in echinococcosis. I. Parasite biomass and antibody response in three strains of inbred mice against graded doses of Echinococcus multilocularis cysts.

Authors:  Z Ali-Khan
Journal:  J Parasitol       Date:  1974-04       Impact factor: 1.276

8.  Pathogenesis and host response in subcutaneous alveolar hydatidosis. I. Histogenesis of alveolar cyst and a qualitative analysis of the inflammatory infiltrates.

Authors:  Z Ali-Khan; R Siboo
Journal:  Z Parasitenkd       Date:  1980

9.  Cellular changes in the lymphoreticular tissues of C57L/J mice infected with Echinococcus multilocularis cysts.

Authors:  Z Ali-Khan
Journal:  Immunology       Date:  1978-05       Impact factor: 7.397

10.  Alveolar echinococcosis of the liver; studies on 60 operated cases.

Authors:  Y Kasai; I Koshino; N Kawanishi; H Sakamoto; E Sasaki; M Kumagai
Journal:  Ann Surg       Date:  1980-02       Impact factor: 12.969

View more
  15 in total

1.  Cellular immunity in experimental Echinococcus multilocularis infection. II. Sequential and comparative phenotypic study of the periparasitic mononuclear cells in resistant and sensitive mice.

Authors:  S Bresson-Hadni; M Liance; J P Meyer; R Houin; J L Bresson; D A Vuitton
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

2.  Cellular immunity in experimental Echinococcus multilocularis infection. I. Sequential and comparative study of specific in vivo delayed-type hypersensitivity against E. multilocularis antigens in resistant and sensitive mice.

Authors:  M Liance; S Bresson-Hadni; J P Meyer; R Houin; D A Vuitton
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

3.  Nitric oxide-mediated immunosuppression following murine Echinococcus multilocularis infection.

Authors:  W J Dai; B Gottstein
Journal:  Immunology       Date:  1999-05       Impact factor: 7.397

4.  Resistance/susceptibility to Echinococcus multilocularis infection and cytokine profile in humans. I. Comparison of patients with progressive and abortive lesions.

Authors:  V Godot; S Harraga; I Beurton; M Deschaseaux; E Sarciron; B Gottstein; D A Vuitton
Journal:  Clin Exp Immunol       Date:  2000-09       Impact factor: 4.330

5.  Cellular immune response in Echinococcus multilocularis infection in humans. II. Natural killer cell activity and cell subpopulations in the blood and in the periparasitic granuloma of patients with alveolar echinococcosis.

Authors:  D A Vuitton; S Bresson-Hadni; L Laroche; D Kaiserlian; S Guerret-Stocker; J L Bresson; M Gillet
Journal:  Clin Exp Immunol       Date:  1989-10       Impact factor: 4.330

6.  Cellular immune response in Echinococcus multilocularis infection in humans. I. Lymphocyte reactivity to Echinococcus antigens in patients with alveolar echinococcosis.

Authors:  S Bresson-Hadni; D A Vuitton; D Lenys; M Liance; E Racadot; J P Miguet
Journal:  Clin Exp Immunol       Date:  1989-10       Impact factor: 4.330

Review 7.  Echinococcus multilocularis and its intermediate host: a model of parasite-host interplay.

Authors:  Dominique Angèle Vuitton; Bruno Gottstein
Journal:  J Biomed Biotechnol       Date:  2010-03-21

8.  Collagen immunotyping of the hepatic fibrosis in human alveolar echinococcosis.

Authors:  D A Vuitton; S Guerret-Stocker; J P Carbillet; G Mantion; J P Miguet; J A Grimaud
Journal:  Z Parasitenkd       Date:  1986

9.  Interleukin-5 is the predominant cytokine produced by peripheral blood mononuclear cells in alveolar echinococcosis.

Authors:  D Sturm; J Menzel; B Gottstein; P Kern
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

10.  Echinococcus multilocularis: parasite-specific humoral and cellular immune response subsets in mouse strains susceptible (AKR, C57B1/6J) or 'resistant' (C57B1/10) to secondary alveolar echinococcosis.

Authors:  B Gottstein; E Wunderlin; I Tanner
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.